Submitted by Anonymous (not verified) on 23 June 2026 - 11:32
Human medicines European public assessment report (EPAR): Imdylltra, tarlatamab, Date of authorisation: 29/05/2026, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imdylltra, tarlatamab, Date of authorisation: 29/05/2026, Status: Authorised